Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AMI-1, sodium salt | 20324-87-2 | sc-205928 sc-205928A | 5 mg 25 mg | $114.00 $398.00 | 2 | |
AMI-1, sodium salt is an inhibitor of protein arginine methyltransferases (PRMTs), potentially impacting FAM98A's role in PRMT1-induced protein arginine methylation. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
As a bisphosphonate, Zoledronic acid, anhydrous inhibits bone resorption, potentially influencing FAM98A's involvement in skeletal homeostasis and osteoclast function. | ||||||
Calcitonin, Salmon | 47931-85-1 | sc-201167 sc-201167A | 1 mg 5 mg | $154.00 $625.00 | 1 | |
Calcitonin, Salmon reduces osteoclast activity, which may indirectly impact FAM98A's role in skeletal homeostasis and bone remodeling. | ||||||
Odanacatib | 603139-19-1 | sc-364675 sc-364675A sc-364675B | 5 mg 25 mg 250 mg | $218.00 $993.00 $1982.00 | 2 | |
Odanacatib is a Cathepsin K inhibitor, potentially affecting FAM98A's role in osteoclast ruffled border formation and function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an autophagy inhibitor, may affect lysosome function and distribution, indirectly impacting FAM98A's role in osteoclasts. | ||||||
Alendronate acid | 66376-36-1 | sc-337520 | 5 g | $135.00 | 2 | |
Alendronate Sodium Salt Trihydrate, a bisphosphonate, inhibits osteoclast-mediated bone resorption, potentially affecting FAM98A's role in bone metabolism. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin filament formation, potentially affecting FAM98A's involvement in osteoclast morphology and function. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a cysteine protease inhibitor, which could impact lysosomal function and potentially FAM98A's role in osteoclasts. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits vacuolar-type H+-ATPase, potentially affecting lysosomal acidification and FAM98A-related processes in osteoclasts. | ||||||
Risedronic acid | 105462-24-6 | sc-203239 | 100 mg | $107.00 | 2 | |
Risedronic acid is a bisphosphonate that can influence bone turnover, potentially impacting FAM98A′s function in skeletal homeostasis. | ||||||